Lilly for the fifth time this year has announced refunds for overcharges on 340B-acquired drugs.

Lilly for the Fifth Time This Year Announces Refunds for 340B Overcharges

In Pharma IndustryDecember 8, 2022185 Views

Drug manufacturer Eli Lilly for the fifth time this year has announced refunds for overcharges on 340B-acquired drugs. The latest round is for purchases during the first quarter of 2020.

The U.S. Health Resources and Services Administration posted Lilly’s notice yesterday. Lilly said

Drug manufacturer Eli Lilly for the fifth time this year has announced refunds for overcharges on 340B-acquired drugs.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

Lilly for the Fifth Time This Year Announces Refunds for 340B Overcharges

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Tom Mirga